Literature DB >> 10571954

Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient.

M Okubo1, F Kanda, A Horinishi, K Takahashi, S Okuda, K Chihara, T Murase.   

Abstract

Several different mutations in the glycogen-debranching enzyme gene AGL have been found in patients with glycogen storage disease type III (GSD III) to date, but no missense mutations have been reported for GSD III, only nonsense, splicing, and deletion/insertion lesions. Here we describe a novel G1448R missense mutation in a Japanese GSD IIIa patient from a consanguineous family. Sequence analysis of cDNA from the patient' liver specimen revealed two separate nucleotide changes: a G-to-A transition at nucleotide 3737 in exon 26 (3737G>A) and a G-to-C transversion at nucleotide 4742 in exon 33 (4742G>C), both of which result in substitution of glycine by arginine (G1115R and G1448R). Because homo-zygotes for G1115R were found in healthy controls, G1115R seems to be a polymorphism. Restriction fragment length polymorphism analysis with Bsa JI showed that the patient was homozygous for G1448R and that none of the normal controls had the mutation. This missense mutation is located at a putative glycogen-binding site that is indispensable for enzyme activity. Thus, G1448R is likely to be the causative mutation in this patient. This is the first report of a missense mutation associated with GSD III. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571954     DOI: 10.1002/(SICI)1098-1004(199912)14:6<542::AID-HUMU15>3.0.CO;2-0

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.

Authors:  Yoriko Endo; Asako Horinishi; Matthias Vorgerd; Yoshiko Aoyama; Tetsu Ebara; Toshio Murase; Masato Odawara; Teodor Podskarbi; Yoon S Shin; Minoru Okubo
Journal:  J Hum Genet       Date:  2006-09-19       Impact factor: 3.172

2.  Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients.

Authors:  Ili Syazwana Abdullah; Ser-Huy Teh; Fiqri Dizar Khaidizar; Lock-Hock Ngu; Wee-Teik Keng; Sufin Yap; Zulqarnain Mohamed
Journal:  Genes Genomics       Date:  2019-04-26       Impact factor: 1.839

3.  Molecular characterization of Egyptian patients with glycogen storage disease type IIIa.

Authors:  Yoriko Endo; Ekram Fateen; Yoshiko Aoyama; Asako Horinishi; Tetsu Ebara; Toshio Murase; Yoon S Shin; Minoru Okubo
Journal:  J Hum Genet       Date:  2005-09-28       Impact factor: 3.172

4.  Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.

Authors:  Alan Cheng; Mei Zhang; Minoru Okubo; Kaoru Omichi; Alan R Saltiel
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

5.  A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.

Authors:  Alan Cheng; Mei Zhang; Matthew S Gentry; Carolyn A Worby; Jack E Dixon; Alan R Saltiel
Journal:  Genes Dev       Date:  2007-10-01       Impact factor: 11.361

6.  The carbohydrate-binding domain of overexpressed STBD1 is important for its stability and protein-protein interactions.

Authors:  Yuanqi Zhu; Mei Zhang; Amber Renee Kelly; Alan Cheng
Journal:  Biosci Rep       Date:  2014-07-01       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.